Pay in 4 interest-free payments of $31.25 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Currently it is in phase I trials for patients with advanced haematological tumours
with IC50 ~6 nM and 15 nM for G9a and GLP
invasion and anchorage-independent tumor growth of breast cancer cells
Y-320 inhibits IL-15-induced IL-17 production by CD4 T cells with an IC50 of 20 nM
and pharmacodynamic (PD) evaluation of intravenous LY2090314 a GSK3 inhibitor administered in combination with pemetrexed and carboplatin
PF-00835231 Catalog No.:M7483-100 Currently it is in phasePF 00835231 is a 3CLpro (Mpro) inhibitor that may targets SARS CoV 2 protease 3CLpro. Product information CAS Number: 870153 29 0 Molecular Weight: 472. 53 Formula: C24H32N4O6 Chemical Name: N ((S) 1 (((S) 4 hydroxy 3 oxo 1 ((S) 2 oxopyrrolidin 3 yl)butan 2 yl)amino) 4 methyl 1 oxopentan 2 yl) 4 methoxy 1H indole 2 carboxamide Smiles: CC(C)C[C@H](NC(=O)C1=CC2C(=CC=CC=2OC)N1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO InChiKey: QDIMHKWNHMVDJB WBAXXEDZSA N
US$ 12.00
US$ 15.00
US$ 64.00
US$ 28.00